Upgrade to SI Premium - Free Trial

AC Immune SA (ACIU)

2.24 +0.05 (2.28%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

AC Immune reports positive TDP-43 tracer data in ALS patients May 22, 2026 7:00 AM - StreetInsider AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS May 22, 2026 7:00 AM - StreetInsider Form 4 AC Immune SA For: May 15 Filed by: Pfeifer Andrea May 18, 2026 4:29 PM - SEC Filing Form 144 AC Immune SA Filed by: Pfeifer Andrea May 15, 2026 4:30 PM - SEC Filing Form 6-K AC Immune SA For: May 15 May 15, 2026 9:18 AM - SEC Filing Form 6-K AC Immune SA For: May 12 May 12, 2026 8:14 AM - SEC Filing AC Immune CEO Dr Andrea Pfeifer to retire after 23 years May 12, 2026 7:00 AM - StreetInsider AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM May 12, 2026 7:00 AM - Globe NewsWire AC Immune SA (ACIU) Reports Q1 Loss of $0.15 April 30, 2026 7:10 AM - StreetInsider Form 6-K AC Immune SA For: Apr 30 April 30, 2026 7:09 AM - SEC Filing Form 6-K AC Immune SA For: Apr 30 April 30, 2026 7:05 AM - SEC Filing AC Immune First Quarter 2026 Financial and Corporate Updates April 30, 2026 7:05 AM - Globe NewsWire AC Immune doses first patients in final ABATE trial cohort April 30, 2026 7:01 AM - StreetInsider AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease April 30, 2026 7:01 AM - StreetInsider AC Immune starts final cohort in alzheimer's drug trial April 30, 2026 7:01 AM - StreetInsider AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease April 30, 2026 7:00 AM - Globe NewsWire Form 4/A AC Immune SA For: Apr 15 Filed by: Pfeifer Andrea April 16, 2026 12:39 PM - SEC Filing Form 4 AC Immune SA For: Apr 15 Filed by: Pfeifer Andrea April 16, 2026 11:11 AM - SEC Filing Form 144 AC Immune SA Filed by: Pfeifer Andrea April 15, 2026 4:52 PM - SEC Filing Leerink Partners on AC Immune SA (ACIU): Lilly deal amendment is 'great news,' validates platform April 7, 2026 2:44 PM - StreetInsider Form 6-K AC Immune SA For: Apr 02 April 7, 2026 12:46 PM - SEC Filing AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly April 7, 2026 9:41 AM - Globe NewsWire AC Immune amends Lilly collaboration for tau drug development April 7, 2026 7:01 AM - StreetInsider AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly April 7, 2026 7:00 AM - StreetInsider Form 3 AC Immune SA For: Mar 18 Filed by: Zuegel Martin April 1, 2026 4:51 PM - SEC Filing Form 3 AC Immune SA For: Mar 20 Filed by: Donati Piergiorgio March 20, 2026 11:59 AM - SEC Filing AC Immune shows first brain images of TDP-43 pathology in phase 1 trial March 19, 2026 7:00 AM - StreetInsider AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026 March 19, 2026 7:00 AM - StreetInsider Form 3 AC Immune SA For: Mar 18 Filed by: Roberts Christopher James March 18, 2026 1:09 PM - SEC Filing Form 3 AC Immune SA For: Mar 18 Filed by: Buetler Monika March 18, 2026 12:36 PM - SEC Filing Form 3 AC Immune SA For: Mar 18 Filed by: Twyman Roy Ervin March 18, 2026 12:34 PM - SEC Filing Form 3 AC Immune SA For: Mar 18 Filed by: AGUIAR-LUCANDER RENEE March 18, 2026 12:30 PM - SEC Filing Form 3 AC Immune SA For: Mar 18 Filed by: Pfeifer Andrea March 18, 2026 12:20 PM - SEC Filing Form 3 AC Immune SA For: Mar 18 Filed by: June Carl Howard March 18, 2026 12:20 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on AC Immune SA (ACIU) March 16, 2026 6:51 AM - StreetInsider Jefferies Reiterates Buy Rating on AC Immune SA (ACIU): '2025 financials largely immaterial' March 13, 2026 9:05 AM - StreetInsider Form 6-K AC Immune SA For: Mar 13 March 13, 2026 7:02 AM - SEC Filing Form 20-F AC Immune SA For: Dec 31 March 13, 2026 7:01 AM - SEC Filing AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update March 13, 2026 7:00 AM - StreetInsider Full Article List